Dr Reddy's Laboratories Ltd

Dr Reddy’s launches a generic semaglutide injection in Canada, expanding its global generics portfolio and eyeing growth in the high‑margin diabetes and weight‑loss market.

Dr. Reddy’s Laboratories Ltd. is a leading pharmaceutical company that has made significant strides in the healthcare sector, with a diversified approach and commitment to innovation, quality, and affordability.

Dr. Reddy’s Laboratories Ltd has seen a recent surge in stock performance, driven by investor confidence and a solid financial foundation, positioning the company for sustained growth in the global pharmaceutical market.